The article also says that the effects persist after adjusting for BMI: > After adjusting for age, body mass index (BMI), disease severity and other health fac

The article also says that the effects persist after adjusting for BMI: > After adjusting for age, body mass index (BMI), disease severity and other health factors, GLP-1 users still showed significantly lower odds of death, suggesting a strong and independent protective effect. The observed reduction in mortality is also quite large: > Health sites, researchers found that those taking glucagon-like peptide-1 (GLP-1) medications were less than half as likely to die within five years compared to those who weren’t on the drugs (15.5% vs. 37.1%). More research is needed, but if I were diagnosed with colon cancer I would definitely be asking my doctor about the risks vs. potential benefits of getting on GLP-1 meds based on this study alone.